Drugs Controller General of India (DCGI)
- Jan- 2023 -12 JanuaryDH Latest News
DCGI recommends Serum Institute’s Covovax as heterologous booster dose
New Delhi: The Central drug regulatory authority Drugs Controller General of India (DCGI) has recommended market authorisation for Serum…
Read More » - Dec- 2022 -23 DecemberDH Latest News
Govt grants approval for Bharat Biotech’s intranasal Covid vaccine ; To be available on CO-WIN
New Delhi: The nasal vaccine, BBV154, received approval of the Drugs Controller General of India in November for restricted…
Read More » - Oct- 2022 -16 OctoberDH Latest News
‘Inadequate info’ on killer cough syrups; India’s request to WHO
New Delhi: The government-appointed committee investigating claims that four cough syrups produced in India may have contributed to the deaths…
Read More » - 6 OctoberDH NEWS
4 Indian-made cough syrups could potentially be linked to the death of 66 children in Gambia: flags WHO
New Delhi: In the wake of the WHO cautioning that cough syrups manufactured by an Indian company could potentially…
Read More » - Apr- 2022 -26 AprilDH Latest News
DCGI grants restricted emergency use authorisation to Covaxin for 6-12 age group
New Delhi: The Drugs Controller General of India (DCGI) gives restricted emergency use authorisation to Covaxin for the 6-12…
Read More » - Mar- 2022 -5 MarchDH Latest News
SEC recommends to grant emergency use authorisation to Covovax COVID-19 vaccine
New Delhi: The Subject Expert Committee (SEC) recommended to grant emergency use authorisation (EUA) to Serum India of India’s…
Read More »